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supraclavicular and axillary nodes 7 months after PBI in a 
patient with negative sentinel node. Nine patients developed 
distant metastases, 16 patients a contralateral breast cancer 
and 35 patients a second primary cancer. At the last check-
up 240 patients were alive: 238 with no evidence of cancer, 2 
with metastatic breast cancer. 15 patients died: 4 of 
metastatic breast cancer, 5 of another cancer, 3 of different 
causes. The 5-year probability of breast relapse-free survival, 
nodal relapse-free survival and cause specific-free survival 
were 98.1% (95% CI: 96.3-100 ) 99% (95% CI: 97.7-100 ) and 
99.5%(95% CI: 98.4-100 ) respectively. Acute toxicity occurred 
in 95 patients and late toxicity in 85 patients. From different 
risk factors for toxicity (age, tumor size, hormonal therapy, 
chemotherapy) only tamoxifen, was significant factor for late 
toxicity (p<0.0001). Cosmetic results were excellent/good in 
250 patients, fair in 6, unknown in 4. Overall inter-rater 
agreement by physicians and patients on cosmesis was good 
(K value: 0.67). 
Conclusions: Our data demonstrate that PBI with 192Ir 
interstitial multi-catheter HDR brachytherapy is associated 
with a relapse rate comparable to the best published results 
and low late toxicity.  
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Purpose/Objective: Incidence of breast cancer (BC) is 
increasing in the elderly population because of the increase 
in life expectancy and the diffusion of screening trials. Even 
in patients with BC of excellent prognosis, ipsilateral breast 
tumour recurrence (IBTR) after conservative surgery without 
adjuvant therapy is still very high. IBTR was reduced by 
either radiotherapy (RT) or hormonal therapy but to a greater 
extent by the receipt of both treatments. Whole breast 
irradiation (WBI) remains the standard of care after 
conserving surgery but the management of adjuvant radiation 
therapy in the elderly has become a medical challenge 
because of the poor compliance of patients to conventional 
RT. We analyzed the recurrences rate and the safety profile 
of a subset of patients age 70 years or older of a phase 3 trial 
comparing APBI and WBI. 
Materials and Methods: The trial enrolled 520 women aged 
more than 40 years affected by early BC, with a maximum 
pathological tumour size of 25 mm. Patients were randomly 
assigned in a 1:1 ratio to receive either WBI or APBI using 
IMRT. The APBI arm received a total dose of 30 Gy to the 
tumour bed in 5 daily fractions. The WBI arm received 50 Gy 
in 25 fractions, followed by a boost of 10 Gy in 5 fractions. 
The primary endpoint was occurrence of IBTR; this trial is 
registered with ClinicalTrials.gov, number NCT02104895. 
Results: A total of 114 patients aged more than 70 years 
were analysed (58 in the WBI arm, 56 in the APBI arm). Most 
patients had pathological T1 stage (86%), nuclear grade G1-2 
(73.2%), positive hormonal status (94.7%), negative HER2 
status (83.3%), and luminal-A molecular subtype (74.6%); all 
these features were well balanced between the two arms. 
At a median follow-up of 5.0 years (range 3.4-7.0), the IBTR 
rate was 2% (one case) in the APBI group and 1.9% in the WBI 
group (one case). No significant difference emerged between 
the two groups (log rank test p=0.93). The APBI group 
presented significantly better results considering acute skin 
toxicity (p=0.0001). Major recorded events and safety profile 
of this subgroup of patients were presented in Table 1. 
 
 
Conclusions: Our results confirmed the low rate of IBTR in 
this subgroup of patients, which could benefit in terms of 
quality of life in a reduction of irradiated volume. Omission 
of WBI after conservative surgery in elderly is still 
controversial, according to the indolent behaviour of BC in 
these patients. Further investigations are strongly needed to 
select a subset of tumours of excellent prognosis, such as 
luminal A, to treat with exclusive APBI or hormonal therapy. 
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Purpose/Objective: To report 2-year cosmetic outcome of a 
randomized trial comparing prone and supine whole-breast 
irradiation (WBI) in large breasted patients 
Materials and Methods: Between December 29, 2010, and 
December 12, 2012, 100 patients with at least a (European) 
cup size C presenting for WBI were randomized between 
supine multi-beam and prone tangential field intensity 
modulated radiotherapy. All patients were treated to 40,05 
Gy in 15 fractions, followed by a boost of 10 Gy in 4 fractions 
if indicated. Digital photographs were taken in standard 
conditions before and 2-year after radiotherapy with markers 
on the nipples, the suprasternal notch and the xyphoid. A 
photograph was taken with the arms alongside the body one 
with the arms up. Cosmesis was objectively scored using the 
commercially available BCCT.core software of the INESC 
Porto Breast Research Group (1). A subjective scoring was 
done by 3 observers on a 4-point scale: excellent – good – fair 
– poor. The difference in cosmesis was analyzed with 0 – no 
difference or better cosmesis, 1 – cosmesis one category 
